Cartesian Therapeutics Inc. (RNAC) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Cartesian Therapeutics In...

    NASDAQ: RNAC · Real-Time Price · USD
    9.46
    -0.61 (-6.06%)
    At close: Sep 25, 2025, 3:59 PM
    9.57
    1.16%
    After-hours: Sep 25, 2025, 04:19 PM EDT

    Cartesian Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 38.91M 26M 110.78M 85.08M
    Cost of Revenue
    		 n/a 1.55M 2.04M n/a
    Gross Profit
    		 38.91M 24.45M 108.74M 85.08M
    Operating Income
    		 -43.9M -86.42M 14.54M -4.6M
    Interest Income
    		 7.39M 4.96M n/a n/a
    Pretax Income
    		 -77.14M -238.71M 34.77M -9.72M
    Net Income
    		 -77.42M -219.71M 35.38M -25.69M
    Selling & General & Admin
    		 30.13M 39.03M 23.86M 20.94M
    Research & Development
    		 45.1M 71.84M 72.38M 68.74M
    Other Expenses
    		 7.58M n/a -2.04M n/a
    Operating Expenses
    		 82.81M 110.87M 94.2M 89.67M
    Interest Expense
    		 n/a 2.83M 3.03M 2.84M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 82.81M 112.42M 96.24M 89.67M
    Income Tax Expense
    		 287K -19M -609K 15.97M
    Shares Outstanding (Basic)
    		 25.91M 5.17M 4.02M 3.18M
    Shares Outstanding (Diluted)
    		 155.11M 5.17M 4.05M 3.18M
    EPS (Basic)
    		 -2.99 -49.76 7.33 -6.74
    EPS (Diluted)
    		 -0.5 -49.76 3.00 -6.6
    EBITDA
    		 -77.14M -235.06M 39.84M -5.16M
    EBIT
    		 -77.14M -235.88M 37.8M -6.88M
    Depreciation & Amortization
    		 1.15M 843K 2.04M 1.72M

    Add to Watchlist